GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (XPAR:ALBPS) » Definitions » Cash Flow from Others

Biophytis (XPAR:ALBPS) Cash Flow from Others : €2.57 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biophytis Cash Flow from Others?

Biophytis's cash flow from others for the six months ended in Dec. 2023 was €1.51 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was €2.57 Mil.


Biophytis Cash Flow from Others Historical Data

The historical data trend for Biophytis's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Cash Flow from Others Chart

Biophytis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.32 18.07 2.63 0.51 2.57

Biophytis Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 0.42 0.10 1.06 1.51

Biophytis Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.57 Mil.

Biophytis Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Biophytis's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Biophytis (XPAR:ALBPS) Business Description

Traded in Other Exchanges
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis (XPAR:ALBPS) Headlines

No Headlines